Announcement Clerkenwell Press Office 16/05/2023 Announcement Clerkenwell Press Office 16/05/2023 Clerkenwell Health and Cognitive Research Corporation Partner to Facilitate Transatlantic Psychedelic Research Read More Announcement Clerkenwell Press Office 12/05/2022 Announcement Clerkenwell Press Office 12/05/2022 Why we’re opening Europe’s first commercial psychedelic research facility Read More Opinion Arda Ozcubukcu 22/11/2021 Opinion Arda Ozcubukcu 22/11/2021 Is the UK an ideal location to run psychedelic trials? Read More Opinion Arda Ozcubukcu 21/09/2021 Opinion Arda Ozcubukcu 21/09/2021 Why Psychedelic Drugs Need Specialist Clinical Research Organisations? Read More Announcement Clerkenwell Press Office 08/09/2021 Announcement Clerkenwell Press Office 08/09/2021 Danish and British Psychedelic Startups Partner to Bring Innovative Psychedelics to Patients Read More Announcement Clerkenwell Press Office 10/08/2021 Announcement Clerkenwell Press Office 10/08/2021 Clerkenwell Partners with Leading Preclinical CRO Transpharmation to Advance Psychedelic Clinical Trials in Europe Read More Announcement Clerkenwell Press Office 07/07/2021 Announcement Clerkenwell Press Office 07/07/2021 Clerkenwell Signs First Multi-Million Pound Contract with International Psychedelic Bio-Tech Company Read More Announcement Clerkenwell Press Office 25/06/2021 Announcement Clerkenwell Press Office 25/06/2021 UK Set To Become Hub Of Psychedelic Research Read More Press Coverage Clerkenwell Press Office 22/04/2021 Press Coverage Clerkenwell Press Office 22/04/2021 Clerkenwell Health to Provide Clinical Research Support to Drug Developers • Proactive Investors Read More
Announcement Clerkenwell Press Office 16/05/2023 Announcement Clerkenwell Press Office 16/05/2023 Clerkenwell Health and Cognitive Research Corporation Partner to Facilitate Transatlantic Psychedelic Research Read More
Announcement Clerkenwell Press Office 12/05/2022 Announcement Clerkenwell Press Office 12/05/2022 Why we’re opening Europe’s first commercial psychedelic research facility Read More
Opinion Arda Ozcubukcu 22/11/2021 Opinion Arda Ozcubukcu 22/11/2021 Is the UK an ideal location to run psychedelic trials? Read More
Opinion Arda Ozcubukcu 21/09/2021 Opinion Arda Ozcubukcu 21/09/2021 Why Psychedelic Drugs Need Specialist Clinical Research Organisations? Read More
Announcement Clerkenwell Press Office 08/09/2021 Announcement Clerkenwell Press Office 08/09/2021 Danish and British Psychedelic Startups Partner to Bring Innovative Psychedelics to Patients Read More
Announcement Clerkenwell Press Office 10/08/2021 Announcement Clerkenwell Press Office 10/08/2021 Clerkenwell Partners with Leading Preclinical CRO Transpharmation to Advance Psychedelic Clinical Trials in Europe Read More
Announcement Clerkenwell Press Office 07/07/2021 Announcement Clerkenwell Press Office 07/07/2021 Clerkenwell Signs First Multi-Million Pound Contract with International Psychedelic Bio-Tech Company Read More
Announcement Clerkenwell Press Office 25/06/2021 Announcement Clerkenwell Press Office 25/06/2021 UK Set To Become Hub Of Psychedelic Research Read More
Press Coverage Clerkenwell Press Office 22/04/2021 Press Coverage Clerkenwell Press Office 22/04/2021 Clerkenwell Health to Provide Clinical Research Support to Drug Developers • Proactive Investors Read More
